Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.67	7.62	0.53	0.31
Short-Term Investments	-	-	-	1
Cash & Short-Term Investments	3.67	7.62	0.53	1.31
Cash Growth	-51.80%	1331.53%	-59.41%	-
Receivables	-	-	-	0
Prepaid Expenses	1.93	-	0.02	0.02
Other Current Assets	0.08	-	-	-
Total Current Assets	5.68	7.62	0.55	1.33
Property, Plant & Equipment	1.05	1.35	0.31	0.51
Total Assets	6.72	8.97	0.86	1.84
Accounts Payable	0.74	0.58	0.14	0.15
Accrued Expenses	1.43	0.58	0.01	0.01
Current Portion of Leases	0.19	0.25	0.13	0.21
Current Unearned Revenue	-	-	0.15	-
Other Current Liabilities	-	-	0.01	0
Total Current Liabilities	2.37	1.41	0.44	0.37
Long-Term Debt	-	2.98	1.62	-
Long-Term Leases	0.27	0.46	0.06	0.19
Other Long-Term Liabilities	3.58	-	1.08	0.95
Total Liabilities	6.22	4.86	3.19	1.51
Common Stock	0	-	0.02	0.02
Additional Paid-In Capital	44.96	0.88	0.65	0.64
Retained Earnings	-44.32	-33.18	-38.45	-35.76
Total Common Equity	0.64	-32.29	-37.78	-35.11
Minority Interest	-0.13	-	-	-
Shareholders' Equity	0.51	4.11	-2.34	0.33
Total Liabilities & Equity	6.72	8.97	0.86	1.84
Total Debt	0.46	3.7	1.81	0.4
Net Cash (Debt)	3.21	3.92	-1.28	0.91
Net Cash Growth	-18.17%	-	-	-
Net Cash Per Share	0.44	0.98	-0.60	0.43
Filing Date Shares Outstanding	9.93	8.79	2.22	2.14
Total Common Shares Outstanding	9.42	2.47	2.22	2.14
Working Capital	3.31	6.21	0.11	0.96
Book Value Per Share	0.07	-13.09	-17.03	-16.37
Tangible Book Value	0.64	-32.29	-37.78	-35.11
Tangible Book Value Per Share	0.07	-13.09	-17.03	-16.37
Machinery	0.97	0.87	0.38	0.37

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q